Natural history of disease

Last updated

Autopsy (1890) by Enrique Simonet. Enrique Simonet - La autopsia 1890.jpg
Autopsy (1890) by Enrique Simonet.

The natural history of disease is the course a disease takes in individual people from its pathological onset ("inception") until its resolution (either through complete recovery or eventual death). [1] The inception of a disease is not a firmly defined concept. [1] The natural history of a disease is sometimes said to start at the moment of exposure to causal agents. [2] Knowledge of the natural history of disease ranks alongside causal understanding in importance for disease prevention and control. Natural history of disease is one of the major elements of descriptive epidemiology. [2]

Contents

As an example, the cartilage of the knee, trapeziometacarpal and other joints deteriorates with age in most humans (osteoarthritis). There are no disease-modifying treatments for osteoarthritis---no way to slow, arrest, or reverse this pathophysiological process. There are only palliative/symptomatic treatments such as analgesics and exercises. In contrast, consider rheumatoid arthritis, a systemic inflammatory disease that damages articular cartilage throughout the body. There are now treatments that can modify that auto-immune inflammatory process (immune modulating drugs) that can slow the progression of the disease. Because these medications can alter the natural history of disease, they are referred to as disease-modifying antirheumatic drugs. [3]

The subclinical (pre-symptomatic) and clinical (symptomatic) evolution of disease is the natural progression of a disease without any medical intervention. It constitutes the course of biological events that occurs during the development of the origin of the diseases [4] (etiologies) to its outcome, whether that be recovery, chronicity, or death. [5]

In regards to the natural history of disease, the goal of the medical field is to discover all of the different phases and components of each pathological process in order to intervene as early as possible and change the course of the disease before it leads to the deterioration of a patient's health. [6]

There are two complementary perspectives for characterizing the natural history of disease. The first is that of the family doctor, who, by means of detailed clinical histories of each patient, can determine the presence of and characteristics of any new health problems. In contrast to this individualized view, the second perspective is that of the epidemiologist, who, through a combination of health records and biostatistical data, can discover new diseases and their respective evolutions, which is more of a population view.

Phases of disease

Pre-pathogenic period

In the pre-pathogenic period, the disease originates, but the patient doesn't yet present clinical symptoms or changes in his/her cells, tissues, or organs. This phase is defined by the host conditions, the disease agent (such as microorganisms and pathogens), and the environment.[ citation needed ]

Pathogenic period

The pathogenic period is the phase in which there are changes in the patient's cells, tissues, or organs, but the patient still doesn't notice any symptoms or signs of disease. This is a subclinical phase that can be subdivided into two more phases:

Incubation period vs. latency period

In transmissible diseases (like the flu), we refer to this phase as the incubation period because it's the time in which microorganisms are multiplying and producing toxins. It's fast-evolving and can last hours to days.[ citation needed ]

However, in degenerative and chronic diseases (like osteoarthritis and dementia), we refer to this phase as the latency period because it has a very slow evolution that can last months to years.[ citation needed ]

Clinical period

The clinical period is when the patient finally presents clinical signs and symptoms. That is: when the disease is clinically expressed and the affected seek health care. During this phase, if the pathological process keeps evolving spontaneously without medical intervention, it will end in one of three ways: recovery, disability, or death. Additionally, this phase can be broken down into three different periods:

  1. Prodromal: the first signs or symptoms appear, which indicates the clinical start of the disease. [7] [8]
  2. Clinical: specific signs and symptoms appear, which allows the doctor to not only identify the disease but also determine the appropriate treatment in hopes of curing the patient or at least preventing long-term damages.
  3. Resolution: the final phase in which the disease disappears, becomes chronic, or leads to death.

Types of prevention

The medical field has developed many different interventions to diagnose, prevent, treat, and rehabilitate the natural course of disease. In artificially changing this evolution of disease, doctors hope to prevent the death of their patients by either curing them or reducing their long-term effects.[ citation needed ]

Primary prevention

Primary prevention is a group of sanitary activities that are carried out by the community, government, and healthcare personnel before a particular disease appears. This includes:

  1. Promotion of health, which is the encouragement and defense of the population's health through actions that fall upon individuals of the community, like, for example, anti-tobacco campaigns for preventing lung cancer and other illnesses associated with tobacco.
  2. Specific protection of health, including environmental safety and food safety. While vaccinations are carried out by medical and nursing personnel, health promotion and protection activities that influence the environment are carried out by other public health professionals.
  3. Chemical treatment, which consists of drug administration to prevent diseases. One example of this is the administration of estrogen in menopausal women to prevent osteoporosis.

According to WHO, one of the instruments of health promotion and prevention is health education, which further deals with the transmission of information, the personal skills, and the self-esteem necessary to adopt measures intended to improve health. Health education involves the spreading of information related not only to underlying social, economic, and environmental conditions that influence health but also to factors and behaviors that put patients at risk. In addition to this, communication about the use of the healthcare system is becoming increasingly more important to primary prevention.

Secondary prevention

Secondary prevention, also called premature diagnosis or premature screening, is an early detection program. More specifically, it's an epidemiological program of universal application that is used to detect serious illnesses in particular, asymptomatic populations during the pre-pathogenic period. This form of prevention can be associated with an effective or curative treatment, and its goal is to reduce the mortality rate.[ citation needed ]

Secondary prevention is based on population screenings, and, in order to justify these screenings, the following predetermined conditions defined by Frame and Carlson in 1975 must be met:

  1. That the disease represents an important health problem that produces noticeable effects on the quality and duration of one's life.
  2. That the disease has a prolonged initial, asymptomatic phase and that its natural history is known.
  3. That an effective treatment is available and accepted by the population in case the disease is found in the initial phase.
  4. That a rapid, reliable, and easily conducted screening test is available, is well-accepted by doctors and patients, and has high sensitivity, specificity, and validity.
  5. That the screening test is cost-effective.
  6. That the early detection of the disease and its treatment during the asymptomatic period reduces global morbidity and/or mortality.

Tertiary prevention

Tertiary prevention is the patient's recovery once the disease has appeared. A treatment is administered in an attempt to cure or palliate the disease or some of its specific symptoms. The recovery and treatment of the patient is carried out both in primary care and in hospital care.[ citation needed ]

Tertiary prevention also occurs when a patient avoids a new contagion as a result of knowledge that he/she gained from having a different illness in the past.[ citation needed ]

Quaternary prevention

Quaternary prevention is the group of sanitary activities that mitigates or entirely bypasses the consequences of the health system's unnecessary or excessive interventions.[ citation needed ]

They are "the actions that are taken to identify patients at risk of overtreatment, to protect them from new medical interventions, and to suggest ethically acceptable alternatives." This concept is coined by the Belgian general physician, Marc Jamoulle, and is included in WONCA's Dictionary of General/Family Practice.[ citation needed ]

Example: Musculoskeletal diseases of senescence

Pre-pathogenic period

Musculoskeletal pathologies such as osteoarthritis of the knee or shoulder (rotator cuff) tendinopathy are aspects of normal human aging. [9] Most humans eventually have evidence of these disease on imaging. In other words, they are diseases of senescence. In a sense, all humans are in the "pre-pathogenic period" for these diseases. [10]

Pathogenic period

Latency period

Osteoarthritis and tendinopathy can remain unnoticed (asymptomatic) for years or even decades. For instance, when one shoulder with tendinopathy develops painful movement, imaging of the opposite symptom-free shoulder tends to identify comparable pathology. [11] [12]

Clinical period

  1. Prodromal: The first time a person notices pain or stiffness associated with osteoarthritis or tendinopathy, it may be misperceived as a new pathology and even as an injury. [13] [14] [15] [12]
  2. Clinical: There comes a time when the disease is symptomatic on most days and there may be deformity or stiffness (reduced motion). The person is now aware of the changes in their body. This may be a time of seeking medical advice or treatment.
  3. Resolution: As with all diseases of senescence, there is an accommodation phase a person redefines their sense of self and no longer perceives the disease as needing active care. Another example would be presbyopia, or the need for reading glasses. Once a person understands that they need glasses to read, they adjust and this is no longer a medical problem.

Types of prevention

The concept of prevention doesn't apply to musculoskeletal diseases of senescence, because there are no disease modifying treatments, and the pathology seems relatively independent of environmental exposures such as activity level. [10]

Related Research Articles

<span class="mw-page-title-main">Arthritis</span> Type of joint disorder

Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness, warmth, swelling, and decreased range of motion of the affected joints. In some types of arthritis, other organs are also affected. Onset can be gradual or sudden.

<span class="mw-page-title-main">Disease</span> Condition negatively affecting an organism

A disease is a particular abnormal condition that adversely affects the structure or function of all or part of an organism and is not immediately due to any external injury. Diseases are often known to be medical conditions that are associated with specific signs and symptoms. A disease may be caused by external factors such as pathogens or by internal dysfunctions. For example, internal dysfunctions of the immune system can produce a variety of different diseases, including various forms of immunodeficiency, hypersensitivity, allergies, and autoimmune disorders.

A transient ischemic attack (TIA), commonly known as a mini-stroke, is a minor stroke whose noticeable symptoms usually end in less than an hour. TIA causes the same symptoms associated with strokes, such as weakness or numbness on one side of the body, sudden dimming or loss of vision, difficulty speaking or understanding language, slurred speech, or confusion.

<span class="mw-page-title-main">Q fever</span> Coxiella burnetii infection

Q fever or query fever is a disease caused by infection with Coxiella burnetii, a bacterium that affects humans and other animals. This organism is uncommon, but may be found in cattle, sheep, goats, and other domestic mammals, including cats and dogs. The infection results from inhalation of a spore-like small-cell variant, and from contact with the milk, urine, feces, vaginal mucus, or semen of infected animals. Rarely, the disease is tick-borne. The incubation period can range from 9 to 40 days. Humans are vulnerable to Q fever, and infection can result from even a few organisms. The bacterium is an obligate intracellular pathogenic parasite.

<span class="mw-page-title-main">Signs and symptoms</span> Indications of a specific illness, including psychiatric

Signs and symptoms are the observed or detectable signs, and experienced symptoms of an illness, injury, or condition.

<span class="mw-page-title-main">Asymptomatic carrier</span> Organism which has become infected with a pathogen but displays no symptoms

An asymptomatic carrier is a person or other organism that has become infected with a pathogen, but shows no signs or symptoms.

<span class="mw-page-title-main">Glycogen storage disease type II</span> Medical condition

Glycogen storage disease type II, also called Pompe disease, and formerly known as GSD-IIa. It is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. GSD-II and Danon disease are the only glycogen storage diseases with a defect in lysosomal metabolism, and Pompe disease was the first glycogen storage disease to be identified, in 1932 by the Dutch pathologist J. C. Pompe.

<span class="mw-page-title-main">Congenital syphilis</span> Medical condition

Congenital syphilis is syphilis that occurs when a mother with untreated syphilis passes the infection to her baby during pregnancy or at birth. It may present in the fetus, infant, or later. Clinical features vary and differ between early onset, that is presentation before 2-years of age, and late onset, presentation after age 2-years. Infection in the unborn baby may present as poor growth, non-immune hydrops leading to premature birth or loss of the baby, or no signs. Affected newborns mostly initially have no clinical signs. They may be small and irritable. Characteristic features include a rash, fever, large liver and spleen, a runny and congested nose, and inflammation around bone or cartilage. There may be jaundice, large glands, pneumonia, meningitis, warty bumps on genitals, deafness or blindness. Untreated babies that survive the early phase may develop skeletal deformities including deformity of the nose, lower legs, forehead, collar bone, jaw, and cheek bone. There may be a perforated or high arched palate, and recurrent joint disease. Other late signs include linear perioral tears, intellectual disability, hydrocephalus, and juvenile general paresis. Seizures and cranial nerve palsies may first occur in both early and late phases. Eighth nerve palsy, interstitial keratitis and small notched teeth may appear individually or together; known as Hutchinson's triad.

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease which is commonly listed in the family of leukodystrophies as well as among the sphingolipidoses as it affects the metabolism of sphingolipids. Leukodystrophies affect the growth and/or development of myelin, the fatty covering which acts as an insulator around nerve fibers throughout the central and peripheral nervous systems. MLD involves cerebroside sulfate accumulation. Metachromatic leukodystrophy, like most enzyme deficiencies, has an autosomal recessive inheritance pattern.

<span class="mw-page-title-main">Carotid artery stenosis</span> Medical condition

Carotid artery stenosis is a narrowing or constriction of any part of the carotid arteries, usually caused by atherosclerosis.

Overdiagnosis is the diagnosis of disease that will never cause symptoms or death during a patient's ordinarily expected lifetime and thus presents no practical threat regardless of being pathologic. Overdiagnosis is a side effect of screening for early forms of disease. Although screening saves lives in some cases, in others it may turn people into patients unnecessarily and may lead to treatments that do no good and perhaps do harm. Given the tremendous variability that is normal in biology, it is inherent that the more one screens, the more incidental findings will generally be found. For a large percentage of them, the most appropriate medical response is to recognize them as something that does not require intervention; but determining which action a particular finding warrants can be very difficult, whether because the differential diagnosis is uncertain or because the risk ratio is uncertain.

<span class="mw-page-title-main">Genital herpes</span> Infection by herpes simplex viruses of the genitals

Genital herpes is a herpes infection of the genitals caused by the herpes simplex virus (HSV). Most people either have no or mild symptoms and thus do not know they are infected. When symptoms do occur, they typically include small blisters that break open to form painful ulcers. Flu-like symptoms, such as fever, aching, or swollen lymph nodes, may also occur. Onset is typically around 4 days after exposure with symptoms lasting up to 4 weeks. Once infected further outbreaks may occur but are generally milder.

Dientamoebiasis is a medical condition caused by infection with Dientamoeba fragilis, a single-cell parasite that infects the lower gastrointestinal tract of humans. It is an important cause of traveler's diarrhea, chronic abdominal pain, chronic fatigue, and failure to thrive in children.

<span class="mw-page-title-main">Subclinical infection</span> Nearly or completely asymptomatic infection

A subclinical infection—sometimes called a preinfection or inapparent infection—is an infection by a pathogen that causes few or no signs or symptoms of infection in the host. Subclinical infections can occur in both humans and animals. Depending on the pathogen, which can be a virus or intestinal parasite, the host may be infectious and able to transmit the pathogen without ever developing symptoms; such a host is called an asymptomatic carrier. Many pathogens, including HIV, typhoid fever, and coronaviruses such as COVID-19 spread in their host populations through subclinical infection.

<span class="mw-page-title-main">Lhermitte–Duclos disease</span> Medical condition

Lhermitte–Duclos disease (LDD), also called dysplastic gangliocytoma of the cerebellum (DGC), is a rare, slowly growing tumor of the cerebellum, a gangliocytoma sometimes considered to be a hamartoma, characterized by diffuse hypertrophy of the granular layer of the cerebellum. It is often associated with Cowden syndrome. It was described by Jacques Jean Lhermitte and P. Duclos in 1920.

<span class="mw-page-title-main">Sexually transmitted infection</span> Infection transmitted through human sexual behavior

A sexually transmitted infection (STI), also referred to as a sexually transmitted disease (STD) and the older term venereal disease (VD), is an infection that is spread by sexual activity, especially vaginal intercourse, anal sex, oral sex, or sometimes manual sex. STIs often do not initially cause symptoms, which results in a risk of passing the infection on to others. Symptoms and signs of STIs may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain. Some STIs can cause infertility.

<span class="mw-page-title-main">Post-traumatic arthritis</span> Medical condition

Post-traumatic arthritis (PTAr) is a form of osteoarthritis following an injury to a joint.

<span class="mw-page-title-main">Latent period (epidemiology)</span> Time interval between infection by a pathogen and the individual becoming infectious

In epidemiology, particularly in the discussion of infectious disease dynamics (modeling), the latent period is the time interval between when an individual or host is infected by a pathogen and when that individual becomes infectious, i.e. capable of transmitting pathogens to other susceptible individuals.

<span class="mw-page-title-main">Infectious period</span>

In epidemiology, particularly in the discussion of infectious disease dynamics, the infectious period is the time interval during which a host is infectious, i.e. capable of directly or indirectly transmitting pathogenic infectious agents or pathogens to another susceptible host. The infectious period can start before, during or after the onset of symptoms, and it may stop before or after the symptoms stop showing. It is also known in the literature by a variety of synonymous terms such as the infective period, the period of infectiousness, communicability period, the period of communicability, contagious period, the period of contagiousness, transmission period or transmissibility period. The degree of infectiousness is not constant but varies through the infectious period.

<span class="mw-page-title-main">Symptoms of COVID-19</span> Overview of the symptoms of COVID-19

The symptoms of COVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness. Common symptoms include coughing, fever, loss of smell (anosmia) and taste (ageusia), with less common ones including headaches, nasal congestion and runny nose, muscle pain, sore throat, diarrhea, eye irritation, and toes swelling or turning purple, and in moderate to severe cases, breathing difficulties. People with the COVID-19 infection may have different symptoms, and their symptoms may change over time. Three common clusters of symptoms have been identified: one respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; and a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. In people without prior ear, nose, or throat disorders, loss of taste combined with loss of smell is associated with COVID-19 and is reported in as many as 88% of symptomatic cases.

References

  1. 1 2 Porta, M, ed. (2014). "Natural history of disease". A Dictionary of Epidemiology (5th ed.). Oxford: Oxford University Press. pp. 193–194. ISBN   978-0-19-939005-2.
  2. 1 2 Bhopal, RS (2008). "Interrelated concepts in the epidemiology of disease: Natural history, spectrum, iceberg, population patterns, and screening". Concepts of epidemiology: Integrating the ideas, theories, principles, and methods of epidemiology (2nd ed.). Oxford: Oxford University Press. doi:10.1093/acprof:oso/9780199543144.001.0001. ISBN   9780199543144.
  3. ↑ Benjamin, Onecia; Goyal, Amandeep; Lappin, Sarah L. (2022), "Disease Modifying Anti-Rheumatic Drugs (DMARD)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29939640 , retrieved 2022-07-01
  4. ↑ Origin Of Diseases Zero Vaginal Discharge is Health, It is a Medical Approach to the Origin of Diseases. Turkish Gynaecologist Doctor Mesut Bayraktar, https://web.archive.org/web/20230707105033/https://muglakadindogum.net/
  5. ↑ "Guiscafré Gallardo H, Salmerón Castro J. Historia natural y curso clínico de la enfermedad. p.117-30" (PDF). Archived from the original (PDF) on 20 August 2010. Retrieved 26 December 2011.
  6. ↑ Morales Bedoya A. Historia natural de la enfermedad y niveles de prevención (definición de conceptos).
  7. ↑ "pródromo | Definición | Diccionario de la lengua española | RAE - ASALE".
  8. ↑ Staff, Equipo (May 23, 1998). Diccionario médico. Elsevier España. ISBN   9788445804865 – via Google Books.
  9. ↑ Dean BJF, Dakin SG, Millar NL, Carr AJ. Review: Emerging concepts in the pathogenesis of tendinopathy. Surgeon. 2017 Dec;15(6):349-354. doi: 10.1016/j.surge.2017.05.005. Epub 2017 Jun 12. PMID 28619548; PMCID: PMC5714045.
  10. 1 2 Kirkwood, T. B. L. (1977). "Evolution of ageing". Nature. 270 (5635): 301–304. Bibcode:1977Natur.270..301K. doi:10.1038/270301a0. ISSN   1476-4687. PMID   593350. S2CID   492012.
  11. ↑ Onishi K, Utturkar A, Chang E, Panush R, Hata J, Perret-Karimi D. Osteoarthritis: A Critical Review. Crit Rev Phys Rehabil Med. 2012;24(3-4):251-264. doi: 10.1615/CritRevPhysRehabilMed.2013007630. PMID 25750483; PMCID: PMC4349405.
  12. 1 2 Liu, Tiffany C.; Leung, Nina; Edwards, Leonard; Ring, David; Bernacki, Edward; Tonn, Melissa D. (2017). "Patients Older Than 40 Years With Unilateral Occupational Claims for New Shoulder and Knee Symptoms Have Bilateral MRI Changes". Clinical Orthopaedics and Related Research. 475 (10): 2360–2365. doi:10.1007/s11999-017-5401-y. ISSN   1528-1132. PMC   5599397 . PMID   28600690.
  13. ↑ Lemmers, Maartje; Versluijs, Yvonne; Kortlever, Joost T. P.; Gonzalez, Amanda I.; Ring, David (2020-12-16). "Misperception of Disease Onset in People with Gradual-Onset Disease of the Upper Extremity". The Journal of Bone and Joint Surgery. American Volume. 102 (24): 2174–2180. doi:10.2106/JBJS.20.00420. hdl: 1887/3638637 . ISSN   1535-1386. PMID   33027085. S2CID   222211926.
  14. ↑ van Hoorn, Bastiaan T.; Wilkens, Suzanne C.; Ring, David (2017). "Gradual Onset Diseases: Misperception of Disease Onset". The Journal of Hand Surgery. 42 (12): 971–977.e1. doi:10.1016/j.jhsa.2017.07.021. ISSN   1531-6564. PMID   28899587.
  15. ↑ Furlough, Kenneth; Miner, Harrison; Crijns, Tom J.; Jayakumar, Prakash; Ring, David; Koenig, Karl (2021). "What factors are associated with perceived disease onset in patients with hip and knee osteoarthritis?". Journal of Orthopaedics. 26: 88–93. doi:10.1016/j.jor.2021.07.013. ISSN   0972-978X. PMC   8318889 . PMID   34341628.

Bibliography

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.